Search Results - "Ford, ML"

Refine Results
  1. 1

    Sepsis erodes CD8+ memory T cell‐protective immunity against an EBV homolog in a 2B4‐dependent manner by Xie, Jianfeng, Crepeau, Rebecca L., Chen, Ching‐wen, Zhang, Wenxiao, Otani, Shunsuke, Coopersmith, Craig M., Ford, Mandy L.

    Published in Journal of leukocyte biology (01-03-2019)
    “…Epstein–Barr virus (EBV) reactivation commonly occurs following sepsis, but the mechanisms underlying this are unknown. We utilized a murine EBV homolog (gHV)…”
    Get full text
    Journal Article
  2. 2

    Belatacept‐Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells by Mathews, D. V., Wakwe, W. C., Kim, S. C., Lowe, M. C., Breeden, C., Roberts, M. E., Farris, A. B., Strobert, E. A., Jenkins, J. B., Larsen, C. P., Ford, M. L., Townsend, R., Adams, A. B.

    Published in American journal of transplantation (01-09-2017)
    “…Recently, newer therapies have been designed to more specifically target rejection in an effort to improve efficacy and limit unwanted toxicity. Belatacept, a…”
    Get full text
    Journal Article
  3. 3

    Selective CD28 blockade results in superior inhibition of donor-specific T follicular helper cell and antibody responses relative to CTLA-4-Ig by Badell, IR, La Muraglia, GM, Liu, D, Wagener, ME, Ding, G, Ford, ML

    Published in American journal of transplantation (14-08-2017)
    “…Donor-specific antibodies (DSA) are a barrier to improved long-term outcomes following kidney transplantation. Costimulation blockade with CTLA-4-Ig has shown…”
    Get full text
    Journal Article
  4. 4

    An Anti‐CD154 Domain Antibody Prolongs Graft Survival and Induces Foxp3+ iTreg in the Absence and Presence of CTLA‐4 Ig by Pinelli, D. F., Wagener, M. E., Liu, D., Yamniuk, A., Tamura, J., Grant, S., Larsen, C. P., Suri, A., Nadler, S. G., Ford, M. L.

    Published in American journal of transplantation (01-11-2013)
    “…The use of monoclonal antibodies targeting the CD154 molecule remains one of the most effective means of promoting graft tolerance in animal models, but…”
    Get full text
    Journal Article
  5. 5

    Pathogen Stimulation History Impacts Donor‐Specific CD8+ T Cell Susceptibility to Costimulation/Integrin Blockade–Based Therapy by Badell, I. R., Kitchens, W. H., Wagener, M. E., Lukacher, A. E., Larsen, C. P., Ford, M. L.

    Published in American journal of transplantation (01-12-2015)
    “…Recent studies have shown that the quantity of donor‐reactive memory T cells is an important factor in determining the relative heterologous immunity barrier…”
    Get full text
    Journal Article
  6. 6

    Rapamycin ameliorates the CTLA4‐Ig–mediated defect in CD8+ T cell immunity during gammaherpesvirus infection by Pinelli, D. F., Wakeman, B. S., Wagener, M. E., Speck, S. H., Ford, M. L.

    Published in American journal of transplantation (01-10-2015)
    “…Latent viral infections are a major concern among immunosuppressed transplant patients. During clinical trials with belatacept, a CTLA4‐Ig fusion protein,…”
    Get full text
    Journal Article
  7. 7

    Specificity, magnitude, and kinetics of MOG‐specific CD8+ T cell responses during experimental autoimmune encephalomyelitis by Ford, Mandy L., Evavold, Brian D.

    Published in European journal of immunology (01-01-2005)
    “…Experimental autoimmune encephalomyelitis (EAE) has traditionally been thought to be almost exclusively mediated by CD4+ effector T cells. Here, we provide…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Non-Depleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates by Badell, IR, Thompson, PW, Turner, AP, Russell, MC, Avila, JG, Cano, JA, Robertson, JM, Leopardi, FV, Strobert, EA, Iwakoshi, NN, Reimann, KA, Ford, ML, Kirk, AD, Larsen, CP

    Published in American journal of transplantation (15-09-2011)
    “…Costimulation blockade of the CD40/CD154 pathway has been effective at preventing allograft rejection in numerous transplantation models. This strategy has…”
    Get full text
    Journal Article
  12. 12

    Amelioration of Established Experimental Autoimmune Encephalomyelitis by an MHC Anchor-Substituted Variant of Proteolipid Protein 139-151 by Margot, Carrie D, Ford, Mandy L, Evavold, Brian D

    Published in The Journal of immunology (1950) (15-03-2005)
    “…Murine experimental autoimmune encephalomyelitis (EAE) is a CD4+ T cell-mediated autoimmune disorder directed against myelin proteins within the CNS. We…”
    Get full text
    Journal Article
  13. 13

    Regulation of Polyclonal T Cell Responses by an MHC Anchor-Substituted Variant of Myelin Oligodendrocyte Glycoprotein 35-55 by Ford, Mandy L, Evavold, Brian D

    Published in The Journal of immunology (1950) (01-08-2003)
    “…Analogs of immunogenic peptides containing substitutions at TCR contact residues (altered peptide ligands (APLs)) have been used to manipulate Ag-specific T…”
    Get full text
    Journal Article
  14. 14

    Five Years of Experience with the ConnectOregon Multimodal Funding Program by Baker, Teddie A., Bufalino, Michael E., Ford, Mark L., Kale, Steven R.

    Published in Transportation research record (01-01-2010)
    “…The Oregon legislature in 2005 authorized $100 million in state lottery bond revenues to be used for investments in aviation, marine, rail, and transit…”
    Get full text
    Journal Article
  15. 15

    CD43 Modulates Severity and Onset of Experimental Autoimmune Encephalomyelitis by Ford, Mandy L, Onami, Thandi M, Sperling, Anne I, Ahmed, Rafi, Evavold, Brian D

    Published in The Journal of immunology (1950) (15-12-2003)
    “…Experimental autoimmune encephalomyelitis (EAE) is a mouse model of multiple sclerosis characterized by infiltration of activated CD4(+) T lymphocytes into…”
    Get full text
    Journal Article
  16. 16

    An MHC anchor‐substituted analog of myelin oligodendrocyte glycoprotein 35–55 induces IFN‐γ and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis by Ford, Mandy L., Evavold, Brian D.

    Published in European journal of immunology (01-02-2004)
    “…Previous strategies to ameliorate experimental autoimmune encephalitis (EAE) include the treatment of autoreactive T cells with altered peptide ligands, which…”
    Get full text
    Journal Article
  17. 17

    Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes by Ford, Mandy L, Evavold, Brian D

    Published in Molecular immunology (01-02-2004)
    “…The concept of molecular mimicry suggests that microbial pathogens might activate antigen-specific T cells that then cross-react with endogenous antigens and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Neural crest cell lineage segregation in the mouse neural tube by Wilson, Yvette M., Richards, Kay L., Ford-Perriss, Miriam L., Panthier, Jean-Jacques, Murphy, Mark

    Published in Development (Cambridge) (15-12-2004)
    “…Neural crest (NC) cells arise in the dorsal neural tube (NT) and migrate into the embryo to develop into many different cell types. A major unresolved question…”
    Get full text
    Journal Article
  20. 20

    Defining the parameters necessary for T-cell recognition of ligands that vary in potency by Kilgore, Neely E, Ford, Mandy L, Margot, Carrie D, Jones, Daniel S, Reichardt, Peter, Evavold, Brian D

    Published in Immunologic research (01-01-2004)
    “…Identification of the mechanisms by which a T cell is able to sense ligands of varying strength, such as those that mediate tumor growth, viral evasion, and…”
    Get full text
    Journal Article